These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 7296549)

  • 1. Assessment of in vivo effectiveness of tumoricidal chemotherapy and radiation therapy by serial analysis of tumor-associated urinary antigen titers in patients with sarcoma.
    Huth JF; Gupta RK; Morton DL
    Cancer Treat Rep; 1981; 65(11-12):1037-42. PubMed ID: 7296549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential analysis of urinary antigen(s) in patients with sarcoma.
    Huth JF; Gupta RK; Morton DL
    Surg Forum; 1979; 30():150-2. PubMed ID: 538579
    [No Abstract]   [Full Text] [Related]  

  • 3. Caffeine-potentiated radiochemotherapy and function-saving surgery for high-grade soft tissue sarcoma.
    Tsuchiya H; Yamamoto N; Asada N; Terasaki T; Kanazawa Y; Takanaka T; Nishijima H; Tomita K
    Anticancer Res; 2000; 20(3B):2137-43. PubMed ID: 10928167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas.
    Pisters PW; Patel SR; Prieto VG; Thall PF; Lewis VO; Feig BW; Hunt KK; Yasko AW; Lin PP; Jacobson MG; Burgess MA; Pollock RE; Zagars GK; Benjamin RS; Ballo MT
    J Clin Oncol; 2004 Aug; 22(16):3375-80. PubMed ID: 15310783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma.
    Tsuchiya H; Tomita K; Yamamoto N; Mori Y; Asada N
    Anticancer Res; 1998; 18(5B):3651-6. PubMed ID: 9854472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective postoperative evaluation of urinary tumor-associated antigens in sarcoma patients. Correlation with disease recurrence.
    Huth JF; Gupta RK; Eilber FR; Morton DL
    Cancer; 1984 Mar; 53(6):1306-10. PubMed ID: 6692320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative systemic etoposide/ifosfamide/doxorubicin chemotherapy combined with regional hyperthermia in high-risk sarcoma: a pilot study.
    Issels RD; Bosse D; Abdel-Rahman S; Starck M; Panzer M; Jauch KW; Stiegler H; Berger H; Sauer H; Peter K
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S233-7. PubMed ID: 8453705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an enzyme immunoassay to detect and quantitate tumor-associated antigens in the urine of sarcoma patients.
    Huth JF; Gupta RK; Morton DL
    Cancer; 1981 Jun; 47(12):2856-61. PubMed ID: 7020919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favorable outcome of Ewing sarcoma family tumors to multiagent intensive preoperative chemotherapy: a single institution experience.
    Moschovi M; Trimis G; Stefanaki K; Anastasopoulos J; Syriopoulou V; Koultouki E; Tzortzatou-Stathopoulou F
    J Surg Oncol; 2005 Mar; 89(4):239-43. PubMed ID: 15726621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective longitudinal evaluation of doxorubicin-induced cardiomyopathy in sarcoma patients: a report of the late effects surveillance system (LESS).
    Paulides M; Kremers A; Stöhr W; Bielack S; Jürgens H; Treuner J; Beck JD; Langer T;
    Pediatr Blood Cancer; 2006 Apr; 46(4):489-95. PubMed ID: 16333817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preoperative and postoperative chemotherapy of osteogenic sarcoma of the limbs in children].
    Muñoz Villa A; Ocete G; Aymerich ML; Maldonado S; Otheo E; Calvo M; Amaya J
    Med Clin (Barc); 1996 Jun; 107(5):161-4. PubMed ID: 8758673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma.
    Nisman B; Barak V; Shapiro A; Golijanin D; Peretz T; Pode D
    Cancer; 2002 Jun; 94(11):2914-22. PubMed ID: 12115379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?
    Harrison L; Blackwell K
    Oncologist; 2004; 9 Suppl 5():31-40. PubMed ID: 15591420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined chemo-radiation and hyperthermia for locally advanced soft tissue sarcoma: response and toxicity.
    Uno T; Itami J; Kato H
    Anticancer Res; 1995; 15(6B):2655-7. PubMed ID: 8669842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Phase I trial of TNFerade biologic in patients with soft tissue sarcoma in the extremities.
    Mundt AJ; Vijayakumar S; Nemunaitis J; Sandler A; Schwartz H; Hanna N; Peabody T; Senzer N; Chu K; Rasmussen CS; Kessler PD; Rasmussen HS; Warso M; Kufe DW; Gupta TD; Weichselbaum RR
    Clin Cancer Res; 2004 Sep; 10(17):5747-53. PubMed ID: 15355902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of human tumor-associated antigen(s) in urine of patients with cancer.
    Gupta RK; Morton DL
    Surg Forum; 1975; 26():158-60. PubMed ID: 1216096
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of cancer-associated antigen(s) in urine of sarcoma patients.
    Gupta RK; Morton DL
    J Surg Oncol; 1979; 11(1):65-74. PubMed ID: 285312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Coevorden F; van Slooten GW; Kroon BB
    Cancer; 2003 Oct; 98(7):1483-90. PubMed ID: 14508836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of intra-arterial chemotherapy and embolization before limb salvage surgery for osteosarcoma of the lower extremity.
    Zhang HJ; Yang JJ; Lu JP; Lai CJ; Sheng J; Li YX; Hao Q; Zhang SM; Gupta S
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):672-8. PubMed ID: 19296158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial urinary IL-2, IL-6, IL-8, TNFalpha, UBC, CYFRA 21-1 and NMP22 during follow-up of patients with bladder cancer receiving intravesical BCG.
    Sanchez-Carbayo M; Urrutia M; Romani R; Herrero M; Gonzalez de Buitrago JM; Navajo JA
    Anticancer Res; 2001; 21(4B):3041-7. PubMed ID: 11712808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.